Health Canada drug identification number

DIN 02405776 — JAMP NEVIRAPINE 200 MG

JAMP NEVIRAPINE is a tablet of Nevirapine marketed by JAMP PHARMA CORPORATION. The full Nevirapine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02405776
Brand name
JAMP NEVIRAPINE
Active ingredient
Nevirapine
Strength
200 MG
Dosage form
TABLET
Route
ORAL
Manufacturer
JAMP PHARMA CORPORATION
Health Canada status
MARKETED
Drug class
Non-nucleoside reverse transcriptase inhibitor (antiretroviral)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Nevirapine products

DINBrandStrengthFormManufacturerStatus
02318601 AURO-NEVIRAPINE 200 MG TABLET AURO PHARMA INC MARKETED
02387727 MYLAN-NEVIRAPINE 200 MG TABLET MYLAN PHARMACEUTICALS ULC MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.